Anti-inflammatory Effect of Indirubin-3'-Monoxime-5-Sulphonic Acid on Lipopolysaccharide-stimulated Murine Macrophage |
Park, Gang-Baek
(Department of Biomedical Science, Catholic University of Daegu)
Kim, Hyun-Jin (Department of Biomedical Science, Catholic University of Daegu) Heo, Hye-Seon (Department of Biomedical Science, Catholic University of Daegu) Park, Geun-Mook (Department of Biomedical Science, Catholic University of Daegu) Park, Kyung-Woo (Department of Biomedical Science, Catholic University of Daegu) Kim, Jin-Kyung (Department of Biomedical Science, Catholic University of Daegu) |
1 | Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol. 2004. 130: 627-635. DOI ScienceOn |
2 | Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009. 94: 3171-3182. DOI ScienceOn |
3 | Kim JK, Shin EK, Kang YH, Park JH. Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis. J Cell Biochem. 2011. 112:1384-1391. DOI ScienceOn |
4 | Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995. 35: 655 -677. DOI ScienceOn |
5 | McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of nitic oxide synthase. J Exp Med. 1993. 178: 749-754. DOI ScienceOn |
6 | Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-B1 precursor protein and the activation of NF-B. Cell 1994. 78: 773-785. DOI ScienceOn |
7 | Parameswaran N, Patial S. Tumor necrosis factor- signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010. 20: 87-103. DOI ScienceOn |
8 | Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011. 31: 986-1000. DOI ScienceOn |
9 | Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007. 15: 252 -259. DOI ScienceOn |
10 | Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-B. Annu Rev Cell Biol. 1994. 10: 405-455. DOI ScienceOn |
11 | Tizard IR. Immunology: an introduction inflammation. 2nd ed. 1986. pp. 423-441. Saunders College Publishing. |
12 | Weisz A, Cicatiello L, Esumi H. Regulation of the mouse inducibletype nitric oxide synthase gene promoter by interferongamma, bacterical lipopolysaccharideand NG-monomethyl- L-arginene. Biochem J. 1996. 316: 209-215. DOI |
13 | Xiao Z, Hao Y, Liu B, Qian L. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma 2002. 43: 1763-1768. DOI ScienceOn |
14 | Butchar JP, Parsa KV, Marsh CB, Tridandapani S. Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response. Curr Pharm Des. 2006. 12: 4143-4153. DOI ScienceOn |
15 | Baldwin AS Jr. The NF-B and IB proteins: new discoveries and insights. Annu Rev Immunol. 1996. 14: 649-683. DOI ScienceOn |
16 | Botting RM. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses. J Physiol Pharmacol. 2006. 5: S113-S124. |
17 | Bryniarski K, Maresz K, Szczepanik M, Ptak M, Ptak W. Modulation of macrophage activity by proteolytic enzymes. Differential regulation of IL-6 and reactive oxygen intermediates (ROIs) synthesis as a possible homeostatic mechanism in the control of inflammation. Inflammation 2003. 27: 333-340. DOI |
18 | Christie RM. Why is indigo blue? Biotech Histochem. 2007. 82: 51-56. DOI ScienceOn |